Detalles de la búsqueda
1.
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Ann Oncol;
33(2): 181-192, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839016
2.
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
Ann Oncol;
31(12): 1734-1745, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976938
3.
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.
Ann Oncol;
31(2): 274-282, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959344
4.
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC).
Ann Oncol;
28(10): 2451-2457, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961841
5.
Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature.
Ann Oncol;
26(2): 278-88, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942274
6.
Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.
ESMO Open;
8(6): 102197, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070435
7.
Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis.
ESMO Open;
7(3): 100507, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696746
8.
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020).
Clin Transl Oncol;
23(5): 980-987, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33538989
9.
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis.
Cancer Treat Res Commun;
27: 100378, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905962
10.
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Cancer Treat Rev;
89: 102067, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682248
11.
The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer.
J Clin Med;
9(11)2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33207619
12.
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
Lung Cancer;
147: 83-90, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682189
13.
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.
Lung Cancer;
133: 83-87, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200833
14.
Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.
Leukemia;
21(3): 472-9, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17215853
15.
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy.
Leukemia;
21(5): 943-8, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17361226
16.
Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer.
Clin Transl Oncol;
20(7): 881-888, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29139039
17.
A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer.
Sci Rep;
7(1): 10228, 2017 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860486
18.
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)
Clin. transl. oncol. (Print);
23(5): 980-987, mayo 2021. tab
Artículo
en Inglés
| IBECS (España) | ID: ibc-221238
19.
Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916).
Br J Surg;
97(9): 1452; author reply 1452-3, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20683871
20.
Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood.
Leukemia;
17(3): 613-20, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12646952